Alliance Discussion: Finding New Hope in Existing Drugs: a conversation with ARPA-H Project Awardee Dr. David Fajgenbaum, Co-Founder & President of Every Cure
June 13 @ 11:00 am - 11:45 am
Globally, there are millions of people diagnosed with diseases that have no available or approved treatments. Drug repurposing or using an approved drug as a new treatment for another disease has been an effective, but underutilized tool in therapeutic discovery. In February 2024, Every Cure received an ARPA-H Project Award to develop an AI-powered platform, called ML/AI-enabled Therapeutic Repurposing In eXtended uses (MATRIX). Please join us on Thursday, June 13th at 11:00am ET for an alliance discussion with Co-Founder & President of Every Cure, Dr. David Fajgenbaum to learn how he repurposed an existing drug to save his life and now is on a mission to unlock treatments for millions more using the power of AI.